Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, European Medicines Agency, Amsterdam, the Netherlands, from 12/02/2024 to 13/02/2024

Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, European Medicines Agency, Amsterdam, the Netherlands, from 12/02/2024 to 13/02/2024

Opinion/decision on a Paediatric investigation plan (PIP): Atropine (sulfate), decision type: , therapeutic area: , PIP number: P/0416/2022

Opinion/decision on a Paediatric investigation plan (PIP): Atropine (sulfate), decision type: , therapeutic area: , PIP number: P/0416/2022

Opinion/decision on a Paediatric investigation plan (PIP): (E)-4-[(5-Phenyl-1,3,4-thiadiazol-2-yl)oxy]-1-azoniatricyclo[3.3.1.13,7] decane 3,4-dicarboxy-3-hydroxybutanoate hydrate (ABT-126), decision type: , therapeutic area: , PIP number: P/0081/2014

Opinion/decision on a Paediatric investigation plan (PIP): (E)-4-[(5-Phenyl-1,3,4-thiadiazol-2-yl)oxy]-1-azoniatricyclo[3.3.1.13,7] decane 3,4-dicarboxy-3-hydroxybutanoate hydrate (ABT-126), decision type: , therapeutic area: , PIP number: P/0081/2014

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.